http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105435237-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 |
| filingDate | 2015-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105435237-B |
| titleOfInvention | A kind of prasugrel hydrochloride pharmaceutical composition, tablet and preparation method thereof |
| abstract | The invention discloses a kind of prasugrel hydrochloride pharmaceutical composition, tablets and preparation method thereof.The pharmaceutical composition is mainly grouped as by the group of following parts by weight: 10~11 parts of prasugrel hydrochloride, 20~35 parts of pregelatinized starch, 150~170 parts of starch milk saccharide complex, 20 parts of low-substituted hydroxypropyl cellulose, 1.0~3.0 parts of behenyl acid glyceride.The compatibility of the prasugrel hydrochloride tablet made of the pharmaceutical composition, supplementary material is good, reduces the degradation risk of prasugrel hydrochloride bulk pharmaceutical chemicals；Rationally, the quality of the drugs determinant attribute such as content, uniformity of dosage units, dissolution rate, catabolite of tablet is guaranteed for type and the dosage design of supplementary material in formula. |
| priorityDate | 2015-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 49.